Amlodipine Besylate Tablet
Product Images NDC 63629-1023

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 63629-1023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

FDA Label Image

Fig2 (Fig2)

This is a partial report of a study where 1318 patients were evaluated for the effect of Amlodipine and Placebo in relation to baseline vessel disease and stenosis. The report provides data on patients' age, gender, baseline sitting systolic blood pressure, baseline vessel disease, and the number of vessels with stenosis. It also describes the number of patients who received PCI, stent placement, or did not receive stent placement. The hazard ratio is also mentioned. The report states that the mean sitting baseline SBP is 129 mmHg.*

FDA Label Image

Structure (Ima)

FDA Label Image

Label Image (Lbl636291023)

This is a description of a medication called Amlodipine Besylate. The medication comes in the form of tablets and is stored at a temperature of 20°C to 25°C. Each tablet contains 2.5mg of Amlodipine Besylate. The medication is to be kept away from children. It is unclear what NILD, AN, VSN #0516 YO, or NDC 63629-1023-2 refer to.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.